Merrimack Pharmaceuticals, Inc. (MACK) has 20 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は 22NW GP, Inc. 1,241,896 株保有. その他の主要保有者には 22NW, LP および Levy Noah G..
MACK インサイダー保有状況
最大保有者
22NW GP, Inc.
1,241,896 株
インサイダー上位保有者
| # |
氏名 |
役職 |
保有株数 |
最終申告日 |
相対規模 |
| 1 |
22nw Gp, Inc. |
10 Percent Owner |
1,241,896 |
2019-07-25 |
|
| 2 |
22nw, Lp |
10 Percent Owner |
1,205,246 |
2019-04-17 |
|
| 3 |
Levy Noah G. |
Director |
1,119,586 |
2023-01-17 |
|
| 4 |
Ledo Capital, Llc |
Director |
754,108 |
2022-07-15 |
|
| 5 |
Andersen Eric |
Director |
533,151 |
2023-12-28 |
|
| 6 |
Jfl Capital Management, Llc |
10 Percent Owner |
499,194 |
2019-07-02 |
|
| 7 |
Needham Thomas E. Jr. |
Chief Business Officer |
450,000 |
2017-08-03 |
|
| 8 |
Mulroy Robert J. |
President and CEO |
250,000 |
2016-02-10 |
|
| 9 |
Peters Richard |
President and CEO |
225,000 |
2018-12-13 |
|
| 10 |
Laivins Peter N |
Head of Development |
150,000 |
2016-02-10 |
|
| 11 |
Stewart Edward J. |
Head of Commercial |
150,000 |
2016-02-10 |
|
| 12 |
Crocker Gary L |
See Remarks |
133,105 |
2023-08-14 |
|
| 13 |
Schoeberl Birgit M. |
Head of Discovery |
125,000 |
2016-02-10 |
|
| 14 |
Al-wakeel Yasir B. |
CFO and Head of Corp Dev |
105,000 |
2016-02-10 |
|
| 15 |
Khan Fazal R. |
SVP of Manufacturing |
75,000 |
2014-02-13 |
|
| 16 |
Sullivan William A. |
Principal Accounting Officer |
60,000 |
2016-02-10 |
|
| 17 |
Niyikiza Clet M. |
EVP of Development |
50,000 |
2013-03-13 |
|
| 18 |
Drummond Daryl C |
Head of Research |
45,000 |
2018-12-13 |
|
| 19 |
Munsie Jeffrey A |
General Counsel |
45,000 |
2018-12-13 |
|
| 20 |
Franchi Jean M. |
Chief Financial Officer |
45,000 |
2018-12-13 |
|
MACK の保有データがありません。
